supp.fit

Phosphatidylserine: study protocols

22 study groups say how much Phosphatidylserine participants took a day. These are the doses the studies gave. They are not a recommendation.

Phosphatidylserine: what the research found →

Dose per serving from products

1,015 products in our catalogue print how much Phosphatidylserine a serving holds.

Most common: 50 mg to 100 mg, 41% of 1,015 products.

Dose per servingProducts
5 mg or less
35
5 mg to 10 mg
53
10 mg to 25 mg
116
25 mg to 50 mg
206
50 mg to 100 mg
415
100 mg to 250 mg
127
250 mg to 500 mg
49
over 500 mg
14

Dose per serving from research

22 study groups in 17 studies say how much Phosphatidylserine participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 50% of 22 study groups.

Daily doseStudy groups
50 mg to 100 mg
4
100 mg to 250 mg
6
250 mg to 500 mg
11
over 500 mg
1

Commonly used together

12 of 22 study groups took Phosphatidylserine with something else, but nothing that 3 or more different studies gave.

22 study groups

Study
The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial
2025 · PS · Healthy children aged 8–12 years, both sexes
100 mg12 weeks102
The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial
2014 · PS · Children aged 4–14 years with ADHD who had not previously received drug treatment for ADHD
200 mg60 days19
Effects of phosphatidylserine in Alzheimer's disease
1992 · bovine cortex phosphatidylserine (BC-PS) · Patients with probable Alzheimer's disease
300 mg12 weeks—
Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type
1992 · phosphatidylserine · Patients with mild primary degenerative dementia (DSM-III; MMS 15–27)
300 mg8 weeks—
Selegiline in the treatment of mild to moderate Alzheimer-type dementia
1990 · phosphatidylserine group · Adults with mild to moderate Alzheimer-type dementia; ages not reported
200 mg90 days—
Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration
1993 · phosphatidylserine-treated group · Adults aged 65–93 years with moderate to severe cognitive decline
300 mg26 weeks—
Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia
2014 · PS+PA group, Study 2 · Adults aged 50–90 years diagnosed with Alzheimer’s disease
300 mg60 days56
Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia
2014 · PS+PA group, Study 1 · Men and women aged 60–80 years with reported memory problems, without dementia or depression
300 mg90 days40
Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation
1994 · cognitive training combined with phosphatidylserine · patients with probable Alzheimer's disease
400 mg26 weeks18
Effects of phosphatidylserine on exercise capacity during cycling in active males
2006 · phosphatidylserine (PS) · Active males; age not reported
750 mg10 days—
A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial
2018 · PAS · Women aged 18–45 with a diagnosis of premenstrual syndrome (PMS)
400 mg——
Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension
2011 · PS-DHA treatment group (double-blind phase) · Men and women aged 50–90 years with memory complaints and without dementia
300 mg15 weeks79
Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids
2008 · PL-n-3 group · Children aged 8–13 years with impaired visual sustained attention performance
300 mg90 days—
Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
2025 · intervention group · Chinese adults with mild cognitive impairment; mean age 67.95 years; 70 male and 120 female
63 mg1 year95
A Magtein(®), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults
2022 · Magtein®PS group · Healthy Chinese adults aged 18–65 years, men and women
200 mg30 days51
Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: a double-blind placebo-controlled trial followed by an open-label extension
2013 · PS-Omega3, open-label extension · Children with diagnosed ADHD who continued from the double-blind phase
150 mg15 weeks150
Safety of phosphatidylserine containing omega3 fatty acids in ADHD children: a double-blind placebo-controlled trial followed by an open-label extension
2013 · PS-Omega3, double-blind phase · Children with diagnosed ADHD
300 mg15 weeks100
Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension
2011 · PS-DHA continuers (open-label extension) · Men and women aged 50–90 years with memory complaints who had received PS-DHA in the double-blind phase
100 mg15 weeks61
Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension
2011 · PS-DHA naive group (open-label extension) · Men and women aged 50–90 years with memory complaints who had received placebo during the double-blind phase
100 mg15 weeks61
A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study
2014 · PAS 200 group · Healthy, non-smoking men aged 20–45 years, stratified by low or high chronic stress
200 mg6 weeks25
A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study
2014 · PAS 400 group · Healthy, non-smoking men aged 20–45 years, stratified by low or high chronic stress
400 mg6 weeks25
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
2020 · Phytosomal curcumin · Adults aged 18–70 years with overweight (BMI 25–30 kg/m²) and suboptimal fasting plasma glucose (100–125 mg/dL)
120 mg8 weeks40